SM
Sabby Management Portfolio holdings
AUM
$13M
1-Year Return
26.95%
This Quarter Return
-0.58%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$104M
AUM Growth
-$6.8M
(-6.2%)
Cap. Flow
-$7.85M
Cap. Flow
% of AUM
-7.57%
Top 10 Holdings %
Top 10 Hldgs %
75.87%
Holding
124
New
25
Increased
13
Reduced
13
Closed
40
Top Buys
| 1 |
Biogen
BIIB
|
$17.7M |
| 2 |
AstraZeneca
AZN
|
$10.9M |
| 3 |
Reviva Pharmaceuticals
RVPH
|
$3.13M |
| 4 |
XWELL
XWEL
|
$2.57M |
| 5 |
CEL-SCI Corp
CVM
|
$2.36M |
Top Sells
| 1 |
SRNE
Sorrento Therapeutics, Inc.
SRNE
|
$6.76M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$4.25M |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$4.12M |
| 4 |
SPI
SPI Energy Co., Ltd. Ordinary Shares
SPI
|
$3.07M |
| 5 |
Rockwell Medical
RMTI
|
$3.01M |
Sector Composition
| 1 | Healthcare | 88.71% |
| 2 | Industrials | 3.58% |
| 3 | Technology | 1.08% |
| 4 | Consumer Discretionary | 0.7% |
| 5 | Consumer Staples | 0.5% |
